Platelet lipidomics indicates enhanced thrombocyte activation in patients with antiphospholipid syndrome in vivo

URN to cite this document:: urn:nbn:de:bvb:355-epub-766296
DOI to cite this document:: 10.5283/epub.76629

Heimerl, Susanne ; Höring, Marcus

; Burkhardt, Ralph

; Höpting, Matthias ; Sigruener, Alexander ; Liebisch, Gerhard

; Hart, Christina

License: Creative Commons Attribution 4.0
PDF - Published Version
(1MB)

Date of publication of this fulltext: 06 May 2025 05:21

Alternative links to fulltext:DOI Publisher

Details

Preview

Export bibliographical data

Abstract

Background Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by the presence of antiphospholipid antibodies in patients with thromboembolic/thromboinflammatory events and/or obstetric complications. Objectives The aim of this study was to examine whether there are alterations in the platelet lipidome of APS patients in comparison with patients affected by thromboembolism ...